Search research articles
Contact Us
Filters
Showing results (341-350 of 360) with videos related to
Page
of 36
Sort By:
Pharmacology, Biochemistry, and Behavior
|
February 22, 2023
The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism
David B Finlay, Warwick Mackie, Hunter D J Webb, et al.
QJM : Monthly Journal of the Association of Physicians
|
March 11, 2009
Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial
J K Baillie, A A R Thompson, J B Irving, et al.
British Journal of Pharmacology
|
April 3, 1999
N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries
I L Megson, S Morton, I R Greig, et al.
Kidney International
|
March 7, 2006
Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man
K van der Zander, A J H M Houben, D J Webb, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1984
Renal secretion of inactive renin and extraction of angiotensin II in renal artery stenosis in man: factors determining renal vein renin ratio
D J Webb, A M Cumming, F C Adams, et al.
Journal of Hypertension
|
December 1, 1984
Changes in active and inactive renin and in angiotensin II across the kidney in essential hypertension and renal artery stenosis
D J Webb, A M Cumming, F C Adams, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1984
Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function
D M Tillman, L S Malatino, A M Cumming, et al.
Journal of Vascular Research
|
August 13, 2009
Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia
N F Kelland, A J Bagnall, I Morecroft, et al.
Clinical Science (London, England : 1979)
|
May 1, 1990
Peptide histidine valine: its haemodynamic actions and pharmacokinetics in man differ from those of vasoactive intestinal peptide and peptide histidine methionine
J S Gill, Y Yiangou, D J Webb, et al.
Nephron
|
January 1, 1986
Factors affecting renal vein renin ratio in renal artery stenosis. Secretion of inactive renin
L S Malatino, A M Cumming, G P Hodsman, et al.
Page
of 36
Search research articles
Search
Showing results (341-350 of 360) with videos related to
Sort By:
Page
of 36
Pharmacology, Biochemistry, and Behavior
|
February 22, 2023
The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism
David B Finlay, Warwick Mackie, Hunter D J Webb, et al.
QJM : Monthly Journal of the Association of Physicians
|
March 11, 2009
Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial
J K Baillie, A A R Thompson, J B Irving, et al.
British Journal of Pharmacology
|
April 3, 1999
N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries
I L Megson, S Morton, I R Greig, et al.
Kidney International
|
March 7, 2006
Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man
K van der Zander, A J H M Houben, D J Webb, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1984
Renal secretion of inactive renin and extraction of angiotensin II in renal artery stenosis in man: factors determining renal vein renin ratio
D J Webb, A M Cumming, F C Adams, et al.
Journal of Hypertension
|
December 1, 1984
Changes in active and inactive renin and in angiotensin II across the kidney in essential hypertension and renal artery stenosis
D J Webb, A M Cumming, F C Adams, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1984
Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function
D M Tillman, L S Malatino, A M Cumming, et al.
Journal of Vascular Research
|
August 13, 2009
Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia
N F Kelland, A J Bagnall, I Morecroft, et al.
Clinical Science (London, England : 1979)
|
May 1, 1990
Peptide histidine valine: its haemodynamic actions and pharmacokinetics in man differ from those of vasoactive intestinal peptide and peptide histidine methionine
J S Gill, Y Yiangou, D J Webb, et al.
Nephron
|
January 1, 1986
Factors affecting renal vein renin ratio in renal artery stenosis. Secretion of inactive renin
L S Malatino, A M Cumming, G P Hodsman, et al.
Page
of 36